Screening of 31 Lactic Acid Bacteria Strains Identified Levilactobacillus brevis NCTC 13768 as a High-Yield GABA Producer
Authors:
- Desislava TenevaDTDesislava Teneva
- Daniela PenchevaDPDaniela Pencheva
- Tsvetanka Teneva-AngelovaTTTsvetanka Teneva-Angelova
- Svetla DanovaSDSvetla Danova
- Nikoleta AtanasovaNANikoleta Atanasova
- Lili DobrevaLDLili Dobreva
- Manol OgnyanovMOManol Ognyanov
- Ani PetrovaAPAni Petrova
- Aleksandar SlavchevASAleksandar Slavchev
- Vasil GeorgievVasil Georgiev
- Petko DenevPetko Denev
Open Access
- 2 October 2025
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 15 (19) , 10670
Abstract
Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the vertebrate central nervous system, known for its role in promoting sleep, reducing anxiety, regulating blood pressure, and modulating stress, cognition, and behavior. Microbial fermentation offers an effective method for GABA production, with certain lactic acid bacteria (LAB) strains recognized as efficient producers. This study assessed the GABA-producing potential of 31 LAB strains, including isolates from traditional Bulgarian foods and plants. The strains were cultivated in an MRS medium supplemented with 1% monosodium glutamate (MSG), and GABA production was quantified using HPLC after derivatization with dansyl chloride. Most strains produced between 200 and 300 mg/L of GABA. However, Levilactobacillus brevis NCTC 13768 showed much higher productivity, reaching 3830.7 mg/L. To further evaluate its capacity, L. brevis NCTC 13768 was cultivated for 168 h in MRS medium with and without MSG. Without MSG, GABA production peaked at 371.0 mg/L during the late exponential phase. In contrast with MSG, GABA levels steadily increased, reaching 3333.6 mg/L after 168 h. RT-qPCR analyses of the glutamic acid decarboxylase (GAD) system showed that the genes of glutamate decarboxylase (gadB), glutamate-GABA antiporter (gadC), and transcriptional regulator (gadR) are significantly overexpressed when the culture reaches the late stationary phase of growth (96 h after the beginning of cultivation). These results identify L. brevis NCTC 13768 as a high-yield GABA producer, with potential applications in the production of fermented functional foods and beverages.Keywords
Funding Information
- Bulgarian National Science Fund (KП-06-Н71/4)
This publication has 50 references indexed in Scilit:
- Whole-genome analysis, evaluation and regulation of in vitro and in vivo GABA production from Levilactobacillus brevis YSJ3International Journal of Food Microbiology, 2024
- Enhancement of γ-aminobutyric acid (GABA) production by Lactobacillus brevis CRL 2013 based on carbohydrate fermentationInternational Journal of Food Microbiology, 2020
- Controlling foodborne pathogens with natural antimicrobials by biological control and antivirulence strategiesHeliyon, 2020
- In vitro probiotic characterization of high GABA producing strain Lactobacilluas brevis DSM 32386 isolated from traditional “wild” Alpine cheeseAnnals of Microbiology, 2019
- Restoration of GABA production machinery in Lactobacillus brevis by accessible carbohydrates, anaerobiosis and early acidificationFood Microbiology, 2018
- GABA production and structure of gadB / gadC genes in Lactobacillus and Bifidobacterium strains from human microbiotaAnaerobe, 2016
- Non-traditional sources for isolation of lactic acid bacteriaAnnals of Microbiology, 2015
- Biodiversity of Lactic Acid Bacteria2014
- Probiotic-mediated biotransformation of monosodium glutamate to γ-aminobutyric acid: differential production in complex and minimal media and kinetic modellingAnnals of Microbiology, 2013
- Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probioticsBioEssays, 2011